Important: New Login Process
We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.
- If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
- If you log in with a username and password, you will be prompted to set a new password before accessing your account.
Go to the Login Page to get started.
We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a target name.
BioCentury | Aug 2, 2019
Product Development
Boehringer plays catch-up in NASH, dives into new modalities across the board
Keeping to early stage deals, Boehringer places smaller bets on big risks
BioCentury | Nov 1, 2018
Finance
OrbiMed’s NASH Terns
Why OrbiMed led $80 million B round for U.S.-China NASH company Terns
Items per page:
1 - 10 of 12